Compare PCOR & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PCOR | RVTY |
|---|---|---|
| Founded | 2003 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.9B | 11.7B |
| IPO Year | 2021 | N/A |
| Metric | PCOR | RVTY |
|---|---|---|
| Price | $72.37 | $109.18 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 17 | 14 |
| Target Price | $90.18 | ★ $113.46 |
| AVG Volume (30 Days) | 886.6K | ★ 1.1M |
| Earning Date | 02-12-2026 | 02-02-2026 |
| Dividend Yield | N/A | ★ 0.27% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.99 |
| Revenue | $1,275,450,000.00 | ★ $2,813,367,000.00 |
| Revenue This Year | $16.35 | $5.33 |
| Revenue Next Year | $12.16 | $3.03 |
| P/E Ratio | ★ N/A | $52.17 |
| Revenue Growth | ★ 14.94 | 3.37 |
| 52 Week Low | $53.71 | $81.36 |
| 52 Week High | $88.92 | $128.29 |
| Indicator | PCOR | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 43.89 | 68.81 |
| Support Level | $72.65 | $100.98 |
| Resistance Level | $75.22 | $106.39 |
| Average True Range (ATR) | 1.99 | 2.99 |
| MACD | -0.06 | 0.92 |
| Stochastic Oscillator | 53.73 | 69.99 |
Procore Technologies Inc is a cloud-based construction management software company. It generates revenue through subscriptions for access to its software products. The company's products include Design Coordination, BIM, Field Productivity, Project Financials, Invoice Management, Portfolio Financials, Capital Planning, Accounting Integrations, and Analytics. The software products are hosted on its cloud-based SaaS construction management platform. Subscriptions are sold for a fixed fee and revenue is recognized ratably over the term of the subscription.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.